| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |